Clinical Trials Browser

Phase 2 × INDUSTRY × abarelix × Clear all

NCT00100243 2006-09-19

Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy

Phase 2 Completed

Prostatic Neoplasms